Postponement of General Meeting
Filed with ASX · · 2 pages · English
Underwood Capital Limited on 6ix
Earlier from Underwood Capital
- OCS supply agreements for MMJ investee companies
- MediPharm signs customer contracts ahead of TSX-V listing
- PTL completes Phase 2 clinical trial
- Appendix 4C
- Investment in Embark Health
Later from Underwood Capital
- Prospectus
- Update on the PTL Disposal
- Results of Meeting
- MediPharm Labs enters contract with Emerald
- Update on PTL Disposal and MMJ Suspension
Follow Underwood Capital into a list and get an email when it puts out news.
Follow Underwood Capital